Castle Biosciences to Participate in Upcoming Investor Conferences
Castle Biosciences (CSTL) has announced its executive management's participation in three upcoming investor conferences in November 2024. The company will present overviews at the Guggenheim Securities Healthcare Innovation Conference on Nov. 11 at 2:30 p.m. ET and the Stephens 26th Annual Investment Conference on Nov. 20 at 9:00 a.m. ET. Additionally, Castle will be available for one-on-one investor meetings during the UBS Global Healthcare Conference on Nov. 12. Live audio webcasts of the presentations will be accessible through Castle's investor relations website, with replays available after the events.
Castle Biosciences (CSTL) ha annunciato la partecipazione della sua direzione esecutiva a tre prossime conferenze per investitori nel novembre 2024. L'azienda presenterà delle panoramiche alla Guggenheim Securities Healthcare Innovation Conference l'11 novembre alle 14:30 ET e alla Stephens 26th Annual Investment Conference il 20 novembre alle 9:00 ET. Inoltre, Castle sarà disponibile per incontri individuali con gli investitori durante la UBS Global Healthcare Conference il 12 novembre. Le trasmissioni audio in diretta delle presentazioni saranno accessibili tramite il sito delle relazioni con gli investitori di Castle, con le riprese disponibili dopo gli eventi.
Castle Biosciences (CSTL) ha anunciado la participación de su dirección ejecutiva en tres conferencias de inversores que se llevarán a cabo en noviembre de 2024. La compañía presentará resúmenes en la Guggenheim Securities Healthcare Innovation Conference el 11 de noviembre a las 2:30 p.m. ET y en la Stephens 26th Annual Investment Conference el 20 de noviembre a las 9:00 a.m. ET. Además, Castle estará disponible para reuniones individuales con inversores durante la UBS Global Healthcare Conference el 12 de noviembre. Las transmisiones en audio en vivo de las presentaciones estarán disponibles a través del sitio web de relaciones con inversores de Castle, con repeticiones disponibles después de los eventos.
Castle Biosciences (CSTL)는 2024년 11월에 있을 세 가지 투자자 컨퍼런스에 임원들이 참여한다고 발표했습니다. 회사는 11월 11일 오후 2:30 ET에 구겐하임 증권 헬스케어 혁신 컨퍼런스와 11월 20일 오전 9:00 ET에 스티븐스 제26회 연례 투자 회의에서 개요를 발표할 예정입니다. 추가로, Castle은 11월 12일에 있을 UBS 글로벌 헬스케어 컨퍼런스 동안 투자자와의 일대일 회의도 진행할 것입니다. 발표의 생중계 오디오 웹캐스트는 Castle의 투자자 관계 웹사이트를 통해 접근 가능하며, 이벤트 후에는 재생도 가능합니다.
Castle Biosciences (CSTL) a annoncé la participation de sa direction exécutive à trois conférences d’investisseurs à venir en novembre 2024. L’entreprise présentera des aperçus à la Guggenheim Securities Healthcare Innovation Conference le 11 novembre à 14h30 ET et à la Stephens 26th Annual Investment Conference le 20 novembre à 9h00 ET. De plus, Castle sera disponible pour des réunions individuelles avec des investisseurs lors de la UBS Global Healthcare Conference le 12 novembre. Des webcasts audio en direct des présentations seront accessibles via le site des relations avec les investisseurs de Castle, avec des rediffusions disponibles après les événements.
Castle Biosciences (CSTL) hat die Teilnahme seines Führungsteams an drei kommenden Investorenkonferenzen im November 2024 angekündigt. Das Unternehmen wird am 11. November um 14:30 Uhr ET auf der Guggenheim Securities Healthcare Innovation Conference und am 20. November um 9:00 Uhr ET auf der Stephens 26th Annual Investment Conference einen Überblick geben. Zusätzlich wird Castle während der UBS Global Healthcare Conference am 12. November für persönliche Investorenmeetings zur Verfügung stehen. Live-Audio-Webcasts der Präsentationen werden über die Investorenrelations-Website von Castle zugänglich sein, mit Wiederholungen nach den Veranstaltungen.
- None.
- None.
- Guggenheim Securities Healthcare Innovation Conference on Nov. 11, 2024, at 2:30 p.m. Eastern time.
-
Stephens 26th Annual Investment Conference on Nov. 20, 2024, at 9:00 a.m. Eastern time.
Castle will also be available for one-on-one investor meetings during the UBS Global Healthcare Conference on Nov. 12, 2024. Meetings may be requested exclusively through UBS Investment Bank.
Live audio webcasts of the Company’s presentations will be available by visiting Castle Biosciences’ website at https://ir.castlebiosciences.com/events-presentations/default.aspx. Replays of the webcasts will be available following the conclusion of the broadcasts.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241028608077/en/
Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact:
amarshall@castlebiosciences.com
Source: Castle Biosciences Inc.
FAQ
When is Castle Biosciences (CSTL) presenting at the Guggenheim Securities Healthcare Conference?
Which investor conferences will Castle Biosciences (CSTL) attend in November 2024?
How can investors access Castle Biosciences (CSTL) conference presentations?
When is Castle Biosciences (CSTL) presenting at the Stephens Annual Investment Conference?
